BioPharmSignal logoBioPharmSignal

Biotech News

Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study

Achieve Life Sciences (ACHV)Achieve Life SciencesCompany update

ACHV (ACHV) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is achv.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

ACHVAchieve Life Sciences2026-05-19 18:15 EST

Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment

ACHVAchieve Life Sciences2026-09-28 12:30 EST

Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026

SLSSELLAS Life Sciences Group, Inc.2026-09-25 17:00 EST

SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancreatic Cancer

SLSSELLAS Life Sciences Group, Inc.2025-10-13 12:00 EST

SELLAS Life Sciences to Present In Vivo Preclinical Data Demonstrating Statistically Significant Survival Benefit of SLS009 in T-Cell Prolymphocytic Leukemia at the European Society for Medical Oncology (ESMO) Congress 2025

WVEWave Life Sciences2026-09-22 11:30 EST

Wave Life Sciences Announces Appointment of Dr. Monika Vnuk as Chief Business Officer

WVEWave Life Sciences2026-01-12 12:30 EST

Wave Life Sciences Highlights Strategic Priorities for 2026 at the 44th Annual J.P. Morgan Healthcare Conference: Accelerating Development of WVE-007 (INHBE siRNA) for Obesity and Rapidly Advancing RNA Editing Portfolio

KZRKezar Life Sciences2019-11-08 21:13 EST

Kezar Life Sciences to Host Conference Call and Webcast during the American College of Rheumatology Annual Meeting to Discuss Updated Results with KZR-616

KZRKezar Life Sciences2020-05-28 20:01 EST

Kezar Life Sciences to Participate in Fireside Chat During the Jefferies Virtual Healthcare Conference

TECHBio-Techne2026-09-22 13:00 EST

Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration

AZTAAzenta Life Sciences2026-04-07 12:15 EST

Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution

View all latest news

Achieve Life Sciences

Nicotine Dependence Company Achieve Life Sciences develops cytisinicline as a treatment for nicotine dependence and smoking cessation. Cytisinicline Cytisinicline is a plant-derived partial agonist of the nicotinic acetylcholine receptor and is intended as a shorter-course alternative to existing prescription therapies. Phase 3...

Recent company news

ACHVAchieve Life Sciences2026-10-07 12:30 EST

Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications

ACHVAchieve Life Sciences2026-10-06 20:02 EST

Achieve Life Sciences Announces Granting of New Hire Inducement Awards

ACHVAchieve Life Sciences2026-10-01 12:30 EST

Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer

ACHVAchieve Life Sciences2026-09-28 12:30 EST

Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026

ACHVAchieve Life Sciences2026-09-03 21:15 EST

Achieve Life Sciences Announced Granting of New Hire Inducement Awards

Stock data

Close
7.03 USD
Market cap
516.38M USD
Exchange
NASDAQ
Sector
Life Science Tools
Location
United States